CA Patent

CA2997947A1 — Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease

Assigned to Columbia University in the City of New York · Expires 2017-03-16 · 9y expired

What this patent protects

The invention provides for methods for treating Alzheimer's Disease in a subject by reducing ER-MAM localized APP-C99.

USPTO Abstract

The invention provides for methods for treating Alzheimer's Disease in a subject by reducing ER-MAM localized APP-C99.

Drugs covered by this patent

Patent Metadata

Patent number
CA2997947A1
Jurisdiction
CA
Classification
—
Expires
2017-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Columbia University in the City of New York
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.